Shares of Cameco Co. (NYSE:CCJ - Get Free Report) TSE: CCO have been assigned an average recommendation of "Buy" from the twelve ratings firms that are covering the stock, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $70.03.
CCJ has been the subject of a number of recent research reports. Royal Bank of Canada restated an "outperform" rating and issued a $90.00 price objective on shares of Cameco in a report on Tuesday, March 4th. StockNews.com downgraded shares of Cameco from a "hold" rating to a "sell" rating in a research note on Monday. Stifel Nicolaus initiated coverage on Cameco in a research note on Wednesday, March 12th. They set a "buy" rating on the stock. Desjardins began coverage on Cameco in a research note on Friday, April 4th. They issued a "buy" rating for the company. Finally, Glj Research raised their price target on Cameco from $62.76 to $75.68 and gave the stock a "buy" rating in a research report on Wednesday, March 12th.
Get Our Latest Research Report on Cameco
Institutional Investors Weigh In On Cameco
A number of large investors have recently made changes to their positions in the business. FMR LLC lifted its stake in Cameco by 8.7% in the fourth quarter. FMR LLC now owns 22,639,647 shares of the basic materials company's stock worth $1,163,942,000 after acquiring an additional 1,811,876 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Cameco by 1.1% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,846,044 shares of the basic materials company's stock worth $865,729,000 after purchasing an additional 190,337 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Cameco by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 16,784,270 shares of the basic materials company's stock worth $862,997,000 after purchasing an additional 270,102 shares during the period. Alliancebernstein L.P. boosted its stake in shares of Cameco by 13.5% during the 4th quarter. Alliancebernstein L.P. now owns 10,088,407 shares of the basic materials company's stock valued at $518,443,000 after purchasing an additional 1,196,336 shares in the last quarter. Finally, Norges Bank purchased a new position in shares of Cameco during the fourth quarter valued at about $188,595,000. 70.21% of the stock is currently owned by institutional investors.
Cameco Stock Up 3.7 %
Shares of NYSE:CCJ opened at $48.15 on Wednesday. The firm has a market capitalization of $20.96 billion, a PE ratio of 171.95 and a beta of 0.89. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.26 and a current ratio of 2.88. Cameco has a 52-week low of $35.00 and a 52-week high of $62.55. The firm has a fifty day moving average of $42.28 and a 200 day moving average of $49.06.
Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its quarterly earnings data on Thursday, May 1st. The basic materials company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.07). The firm had revenue of $549.58 million for the quarter, compared to the consensus estimate of $890.07 million. Cameco had a net margin of 5.39% and a return on equity of 4.34%. Cameco's revenue for the quarter was up 24.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.13 earnings per share. As a group, research analysts anticipate that Cameco will post 1.27 EPS for the current fiscal year.
About Cameco
(
Get Free ReportCameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cameco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.
While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.